Alumis Inc. (ALMS) vs Apnimed, Inc. (APMD)
A side-by-side comparison of Alumis Inc. and Apnimed, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ALMS
Alumis Inc.
$6.84HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
APMD
Apnimed, Inc.
$21.75HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — ALMS vs APMD
growth of $100 · dividends reinvested · last 1yALMS -74.1% (-74.1%/yr)APMD +35.9% (+35.9%/yr)APMD compounded faster over this window
Log scale — wide-divergence pair
ALMS APMD
Metrics side by side
Total return (annualized)
| Metric | ALMS | APMD |
|---|---|---|
| Total return (1Y) | 69.72% | N/A |
APMD is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.